ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
Unichem Laboratories received a tax order from the Commissioner (Appeals, Thane) for a penalty and interest liability totaling ₹93.66 Crore. The company intends to file an appeal.
Unichem extended the exercise period for 3.75 lakh vested ESOP options from 30-Sep-2026 to 31-Mar-2027. The NRC approved the extension via circular resolution under the 2018 Scheme.
Unichem Laboratories clarified that the recent spurt in trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information to report.
Unichem Laboratories held its 63rd Annual General Meeting on August 11, 2026. The meeting covered the adoption of financial statements and re-appointments of key management personnel.
Unichem Laboratories Ltd reported revenue from operations of ₹632.6 Cr (+20.1% YoY) and net profit of ₹41.5 Cr for Q1 FY27.
Unichem Laboratories received a GST demand order for ₹0.11 Crore from the Additional Commissioner, CGST (Appeals), Dehradun. The company intends to appeal the order.
Unichem Laboratories received a partial allowance for its GSTR TRAN 1 credit appeal. The order creates a demand of ₹1.06 Crore plus interest.
Unichem Laboratories scheduled a board meeting on August 11, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Unichem Laboratories clarified that recent stock price increases are purely market-driven. The company confirmed compliance with all SEBI disclosure requirements and reported no undisclosed material events.